Blood Tests for Alzheimer's Diagnosis Market Report – Research, Industry Analysis Reports and Market Demands

Global Blood Tests for Alzheimer's Diagnosis Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood Tests for Alzheimer's Diagnosis by Type
- 1.3.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type in 2025
- 1.3.3 Single Biomarker Tests
- 1.3.4 Multi-Biomarker Panel Tests
- 1.3.5 Others
1.4 Classification of Blood Tests for Alzheimer's Diagnosis Commercialization Status
- 1.4.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status: 2021 Versus 2025 Versus 2032
- 1.4.2 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share Commercialization Status in 2025
- 1.4.3 Chemiluminescent Immunoassay
- 1.4.4 Single-Molecule and Ultra-Sensitive Immunoassay
- 1.4.5 Mass Spectrometry-Based Testing
- 1.4.6 Others
1.5 Global Blood Tests for Alzheimer's Diagnosis Market by Application
- 1.5.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Clinical Use
- 1.5.3 Non-Clinical Use
1.6 Global Blood Tests for Alzheimer's Diagnosis Market Size & Forecast
1.7 Global Blood Tests for Alzheimer's Diagnosis Market Size and Forecast by Region
- 1.7.1 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
- 1.7.2 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region, (2021-2032)
- 1.7.3 North America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
- 1.7.4 Europe Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
- 1.7.5 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
- 1.7.6 South America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
- 1.7.7 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)

2 Company Profiles

3 Market Competition, by Players

3.1 Global Blood Tests for Alzheimer's Diagnosis Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Blood Tests for Alzheimer's Diagnosis by Company Revenue
- 3.2.2 Top 3 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
- 3.2.3 Top 6 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
3.3 Blood Tests for Alzheimer's Diagnosis Market: Overall Company Footprint Analysis
- 3.3.1 Blood Tests for Alzheimer's Diagnosis Market: Region Footprint
- 3.3.2 Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
- 3.3.3 Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value and Market Share by Type (2021-2026)
4.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2026)
5.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Application (2027-2032)

6 North America

6.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
6.2 North America Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2032)
6.3 North America Blood Tests for Alzheimer's Diagnosis Market Size by Country
- 6.3.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
- 6.3.2 United States Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 6.3.3 Canada Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
7.2 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
7.3 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country
- 7.3.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
- 7.3.2 Germany Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 7.3.3 France Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 7.3.5 Russia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 7.3.6 Italy Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region
- 8.3.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2032)
- 8.3.2 China Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 8.3.3 Japan Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 8.3.5 India Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 8.3.7 Australia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)

9 South America

9.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
9.2 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
9.3 South America Blood Tests for Alzheimer's Diagnosis Market Size by Country
- 9.3.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country
- 10.3.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
- 10.3.4 UAE Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Blood Tests for Alzheimer's Diagnosis Market Drivers
11.2 Blood Tests for Alzheimer's Diagnosis Market Restraints
11.3 Blood Tests for Alzheimer's Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Blood Tests for Alzheimer's Diagnosis Industry Chain
12.2 Blood Tests for Alzheimer's Diagnosis Upstream Analysis
12.3 Blood Tests for Alzheimer's Diagnosis Midstream Analysis
12.4 Blood Tests for Alzheimer's Diagnosis Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Blood Tests for Alzheimer's Diagnosis market size was valued at US$ 74.24 million in 2025 and is forecast to a readjusted size of US$ 131 million by 2032 with a CAGR of 8.4% during review period.
Blood Tests for Alzheimer's Diagnosis refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500–900 per test.
The upstream supply chain of Blood Tests for Alzheimer's Diagnosis mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, Aβ, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer’s disease biomarker research.
The Blood Tests for Alzheimer's Diagnosis market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, Aβ, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer’s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
This report is a detailed and comprehensive analysis for global Blood Tests for Alzheimer's Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Tests for Alzheimer's Diagnosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Tests for Alzheimer's Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Fujirebio, Sysmex, Shimadzu, Diadem, Quanterix, ALZpath, Beckman Coulter Diagnostics, Siemens Healthineers, Vazyme, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood Tests for Alzheimer's Diagnosis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single Biomarker Tests
Multi-Biomarker Panel Tests
Others
Market segment Commercialization Status
Chemiluminescent Immunoassay
Single-Molecule and Ultra-Sensitive Immunoassay
Mass Spectrometry-Based Testing
Others
Market segment by Application
Clinical Use
Non-Clinical Use
Market segment by players, this report covers
Roche
Fujirebio
Sysmex
Shimadzu
Diadem
Quanterix
ALZpath
Beckman Coulter Diagnostics
Siemens Healthineers
Vazyme
Hoyotek
BGI Genomics
Kemei Diagnostics
Maya Lightyear
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Blood Tests for Alzheimer's Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blood Tests for Alzheimer's Diagnosis, with revenue, gross margin, and global market share of Blood Tests for Alzheimer's Diagnosis from 2021 to 2026.
Chapter 3, the Blood Tests for Alzheimer's Diagnosis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Blood Tests for Alzheimer's Diagnosis market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Tests for Alzheimer's Diagnosis.
Chapter 13, to describe Blood Tests for Alzheimer's Diagnosis research findings and conclusion.

Buy now